AveXis (AVXS): World Muscle Society Data Supports Remarkable Efficacy In Infants - BMO
Tweet Send to a Friend
BMO Capital analyst, Ian Somaiya, reiterated his Outperform rating on shares of AveXis (NASDAQ: AVXS) since he believes data presented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE